Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Improved metabolic control may reverse nerve damage in the feet caused by diabetes.

Read the release

Dr. Eero Lindholm has studied two matched groups of diabetes patients that differ in their metabolic control of HbA1c for a period of 1-1.5 years. One group had the same or higher HbA1c values, while the other group had significantly reduced HbA1c values. Significant improvements in the tactile perception of the sole of the foot were only registered in the group that lowered their HbA1c values.

The conclusion is that the VibroSense Meter® can be used to find impaired sensitivity of feet at an early stage. This may motivate and improve compliance of diabetic patients to follow advice and treatment prescribed by the physician. Metabolic control means that patients reduce their long-term blood sugar (HbA1c).

The link between metabolic control and improved nerve function can be clearly demonstrated with Multi-Frequency Vibrometry, which measures the ability to perceive vibration stimuli in the skin at several different frequencies. The examination is more sensitive than the established methods used clinically around the world that usually measures only one frequency.

With Multi-Frequency Vibrometry, diabetic patients can supervise the development of the tactile perception in the feet and, at a very early stage, detect impaired sensitivity which is a part of diabetes neuropathy. Inferior tactile perception may lead to foot ulcers and, in the worst case, to amputation. 

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.